Stellie’s announcement on obtaining government subsidies

Securities code: 603520 Securities abbreviation: Stellie Announcement number: 2026-021

Zhejiang Stell Pharmaceutical Co., Ltd.

Announcement on Obtaining Government Subsidies

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents. Important content reminder:

 Amount of government subsidy received: 7,157,134.22 yuan

 Impact on current profit and loss: Government subsidies related to income of RMB 4,757,134.22 will be included in current profits and losses; government subsidies related to assets of RMB 2,400,000.00 will be included in deferred income. The final impact on the company's profit and loss in 2026 will be subject to the results after annual audit confirmation.

1. Basic information on obtaining government subsidies

From January 1 to May 10, 2026, Zhejiang Stell Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") and its subsidiaries received a total of 7,157,134.22 yuan in various government subsidies. Among them, the government subsidies related to income are 4,757,134.22 yuan, accounting for 46.30% of the absolute value of the company's audited net profit in the most recent fiscal year; the government subsidies related to assets are 2,400,000.00 yuan, accounting for 0.09% of the company's most recent audited net assets.

2. Types of government subsidies and their impact on the company

According to the relevant provisions of "Accounting Standards for Business Enterprises No. 16 - Government Subsidy", the income-related government subsidy of RMB 4,757,134.22 will be included in the current profit and loss; the asset-related government subsidy of RMB 2,400,000.00 will be included in deferred income.

The final impact of the above-mentioned government subsidies on the company's profit and loss in 2026 will be subject to the results after annual audit confirmation. Investors are advised to pay attention to investment risks.

Announcement is hereby made.

Board of Directors of Zhejiang Stell Pharmaceutical Co., Ltd.

May 12, 2026